Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where LifeStance is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- SCHEDULE 13G/A2026-10-05SCHEDULE 13G/A
- 8-K2026-09-11Current report (material event)
- 424B72026-09-10424B7
- 424B72026-09-09424B7
- SCHEDULE 13G/A2026-08-14SCHEDULE 13G/A
- SCHEDULE 13G/A2026-08-11SCHEDULE 13G/A
- 10-Q2026-08-06Quarterly report
- 8-K2026-08-06Current report (material event)
- SCHEDULE 13G2026-07-29SCHEDULE 13G
- 8-K2026-07-07Current report (material event)
- 8-K2026-06-04Current report (material event)
- SCHEDULE 13G/A2026-05-15SCHEDULE 13G/A
- 8-K2026-05-12Current report (material event)
- SCHEDULE 13G/A2026-05-08SCHEDULE 13G/A
- 424B72026-05-08424B7
- 424B72026-05-08424B7
- 10-Q2026-05-07Quarterly report
- 8-K2026-05-07Current report (material event)
- SCHEDULE 13G/A2026-05-06SCHEDULE 13G/A
- ARS2026-04-22Annual report to holders
- DEFA14A2026-04-22DEFA14A
- DEF 14A2026-04-22Proxy statement
- 8-K2026-03-11Current report (material event)
- 8-K2026-03-02Current report (material event)
- 424B72026-02-27424B7
- 424B72026-02-26424B7
- S-82026-02-25Employee stock plan
- 10-K2026-02-25Annual report
- 8-K2026-02-25Current report (material event)
- SCHEDULE 13G/A2026-02-05SCHEDULE 13G/A
- SCHEDULE 13G/A2025-11-13SCHEDULE 13G/A
- SCHEDULE 13G/A2025-11-07SCHEDULE 13G/A
- 10-Q2025-11-06Quarterly report
- 8-K2025-11-06Current report (material event)
- SCHEDULE 13G/A2025-11-05SCHEDULE 13G/A
- 8-K2025-08-22Current report (material event)
- 10-Q2025-08-07Quarterly report
- 8-K2025-08-07Current report (material event)
- 8-K2025-06-06Current report (material event)
- 8-K2025-05-14Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.